Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment: A Leading Driver Behind Surging Prevalence Rates Fueling The Growth Of Urinary Incontinence And Pelvic Organ Prolapse (POP) Devices And Equipment Market Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Industry Market Size Be by 2025?
The market for urinary incontinence and pelvic organ prolapse devices and equipment has seen robust growth in recent years. Projected growth is from $4.01 billion in 2024 to $4.32 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%. The historical growth of this market can be credited to factors such as the aging demographic, increased awareness of women's health, accessibility of healthcare, and customized treatment options.

What's the Long-Term Growth Forecast for the Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Size Through 2029?
The market for urinary incontinence & pelvic organ prolapse devices and equipment is projected to experience robust growth in the upcoming years, with a valuation of $5.48 billion anticipated by 2029. This signifies a compound annual growth rate (CAGR) of 6.1%. This expansion in the forecast period is linked to factors such as the adoption of minimally invasive techniques, growth in emerging markets, the shift towards value-based healthcare, and regulatory backing. Key trends predicted for the forecast period comprise non-surgical treatment alternatives, the introduction of bioresorbable implants, the incorporation of digital health, and increased patient education.

View the full report here:
https://www.thebusinessresearchcompany.com/report/urinary-incontinence-and-pelvic-organ-prolapse-devices-and-equipment-global-market-report

What Are the Key Growth Drivers Fueling the Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Expansion?
The escalated incidence rate for both Pelvic organ prolapses (POP) and urinary incontinence (UI) disorders is a key growth propellant for the urinary incontinence and pelvic organ prolapse (POP) devices and equipment market. The surging incidence rate has spurred equipment manufacturers to innovate more precise and efficient devices to treat these disorders. While POP can affect women at any age, elder women appear to be more susceptible to POP disorders. Reports from the US FDA predict a 46% rise in POP, reaching up to 4.9 million women by 2050. The American Urological Association (AUA/SUFU) published a report stating that the prevalence of stress urinary incontinence (SUI) in women could be as high as 49%. Poor nutritional status groups record a high prevalence rate of stress urinary incontinence, leading to weakened pelvic supports. This alarming prevalence rate is subsequently fuelling the requirement for medical equipment in the urinary incontinence & pelvic organ prolapse devices and equipment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2430&type=smp

What Are the Key Trends Driving Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Growth?
Leading firms in the urinary incontinence and pelvic organ prolapse devices and equipment sector are incorporating innovative systems like the SOLTIVE Super Pulsed Laser System to enhance their market earnings. The SOLTIVE Premium Super Pulsed Laser System (SOLTIVE Laser System) provides the opportunity for faster procedure times, improved patient results, and reduced procedure costs. It is utilised for treating urinary incontinence and other urologic conditions such as kidney stone removal. For example, in January 2022, Olympus, a global company specialising in digital precision technology, launched the SOLTIVESuperPulsed Laser System. This system not only reduces kidney stone procedure time but also provides a more cost-effective solution than Holmium. The SOLTIVE Laser System diminishes procedure time by an average of 20% and offers the potential for superior patient outcomes.

How Is the Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Segmented?
The urinary incontinence & pelvic organ prolapse devices and equipment market covered in this report is segmented -

1) By Type: Urinary Incontinence Devices, Pelvic Organ Prolapse Devices
2) By Urinary Incontinence Devices: Artificial Urinary Sphincters, Electrical Stimulation Devices, Urethral Slings, Catheters
3) By Pelvic Organ Prolapse Devices: Vaginal Mesh, Vaginal Pessary
4) By Incontinence Type: Stress Incontinence, Urge Incontinence, Overflow Incontinence, Functional Incontinence
5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Home Use

Subsegments:
1) By Urinary Incontinence Devices: Catheters (Intermittent, Indwelling, External), Absorbent Products (Pads, Adult Diapers), External Urinary Collection Devices, Electrical Stimulation Devices, Urethral Inserts, Artificial Urinary Sphincter
2) By Pelvic Organ Prolapse Devices: Vaginal Pessaries, Pelvic Floor Stimulation Devices, Surgical Implants, Prolapse Support Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2430&type=smp

Which Companies Are Leading the Charge in Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Innovation?
Major companies operating in the urinary incontinence & pelvic organ prolapse devices and equipment market include Boston Scientific Corporation, Coloplast A/S, Ethicon US, Becton Dickinson and Company, Johnson & Johnson, Teleflex Incorporated, Medtronic plc, COVIDien, Cook Medical, Neomedic International, CooperSurgical, MedGyn, Personal Medical Corp, Integra LifeSciences, Panpac Medical, Medesign, Smiths Medical Inc., Thomas Medical, Kangge Medical, Dr. Arabin GmbH & Co. KG, American Medical Systems Inc., Caldera Medical Inc., Intuitive Surgical, InControl Medical LLC, Atlantic Therapeutics Ltd., Axonics Modulation Technologies, Convatec Group plc, Laborie, NUVO Group, Pelvalon, pfm medical, Promedon, Prosurg Inc., UROMED Kurt Drews KG, Verathon Inc., Vitality Medical, Women's Choice Pharmaceuticals, Zimmer Biomet Holdings Inc.

Which Regions Are Leading the Global Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market in Revenue?
North America was the largest region in the urinary incontinence & pelvic organ prolapse devices and equipment market in 2023. Western Europe was the second-largest region in the urinary incontinence & pelvic organ prolapse devices and equipment market report. The regions covered in the urinary incontinence & pelvic organ prolapse devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2430

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.